Of the reports, were considered serious ( 11.0 reports per 100,000 doses administered). There have been a total of reports ( 56.2 reports per 100,000 doses administered) up to and including.The data on this page may undergo changes as more information about cases becomes available. Doses administered used for reporting rate calculations have been adjusted to account for the delay between vaccination and reporting. The information on this page reflects detailed case information data from the Public Health Agency of Canada’s Canadian Adverse Events Following Immunization Surveillance System (CAEFISS) and Health Canada’s Canada Vigilance program.Learn more about reporting adverse events. If you experience an adverse event following immunization with a COVID-19 vaccine in Canada, please contact your healthcare provider. 596 were considered non-serious (0.007% of bivalent COVID-19 doses administered) and 197 (0.002% of bivalent COVID-19 doses administered) were considered serious. Of the 55,145 individual reports, 793 were following a bivalent vaccine.A total of 98,194,601 vaccine doses have been administered in Canada as of May 26, 2023, including 8,784,275 bivalent doses.Of the individual reports ( of all doses administered), were considered serious ( of all doses administered).We’ll respond to any safety issues right away and will inform Canadians about any risks that arise in Canada. Health Canada, the Public Health Agency of Canada (PHAC), the provinces and territories, and manufacturers continue to closely monitor the safety of COVID-19 vaccines.Evidence indicates that the benefits of COVID-19 vaccines continue to outweigh the risks of the disease.Health Canada and PHAC continue to monitor this closely. In Canada as well, we’ve detected no safety signal of ischemic stroke following COVID-19 mRNA bivalent boosters. As of April 19, 2023, FDA’s monitoring systems and programs have not detected any safety signals for ischemic stroke following COVID-19 mRNA bivalent boosters.No new safety signals have been identified during this reporting period.Total adverse event following immunization reports that were serious
0 kommentar(er)
